• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Leishen Energy Holding Co., Ltd. - Ordinary Shares (NQ:LSE)

    4.570 -0.230 (-4.79%)
    Streaming Delayed Price Updated: 1:19 PM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,162
    Open 4.670
    Bid (Size) 4.550 (100)
    Ask (Size) 4.790 (2,400)
    Prev. Close 4.800
    Today's Range 4.560 - 4.800
    52wk Range 4.030 - 14.99
    Shares Outstanding 15,500,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    HUTCHMED Announces Positive Topline Results of Phase III Part of ESLIM-02 Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma
    From HUTCHMED (China) Limited
    Via GlobeNewswire

    Performance

    YTD
    +7.0%
    +7.0%
    1 Month
    -10.4%
    -10.4%
    3 Month
    -13.8%
    -13.8%
    6 Month
    -19.8%
    -19.8%
    1 Year
    -14.7%
    -14.7%

    More News

    Read More
    News headline image
    HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Fanregratinib in Second-Line Intrahepatic Cholangiocarcinoma
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Zimbabwe government amends proposed changes to the royalty and tax regimes
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
    From AVACTA GROUP PLC
    Via GlobeNewswire
    News headline image
    HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Utilisation of the block admission in respect of ATM Sales Agreement
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Notification of relevant change to significant shareholder
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+ in patients with first line advanced melanoma
    From Scancell Holdings Plc
    Via GlobeNewswire
    News headline image
    HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    Empire to Present at the Precious Metals & Critical Minerals Virtual Investor Conference
    From Virtual Investor Conferences; Empire Metals Limited
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Proposed Changes to Royalty and Tax Regimes in Zimbabwe
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Reminder of Remote Presentation on Publication of Feasibility Study for Bilboes Gold Project in Zimbabwe
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting
    From HUTCHMED (China) Limited
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Publication and Highlights of the Feasibility Study for Bilboes Gold Project
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    UPDATE - Leishen Energy(LSE) Makes a Strong Debut at ADIPEC Abu Dhabi, Embarking on a New Chapter of Strategic Expansion in the Middle East and International Markets
    From Leishen Energy Holding Co., Ltd.
    Via GlobeNewswire
    News headline image
    Caledonia approves quarterly dividend
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc: Abridged Quarterly Results and Details of Management Conference Call for the three and nine months ended September 30, 2025 (“Q3 2025” or “the Quarter”)
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    Leishen Energy(LSE) Makes a Strong Debut at ADIPEC Abu Dhabi, Embarking on a New Chapter of Strategic Expansion in the Middle East and International Markets
    From Leishen Energy Holding Co., Ltd.
    Via GlobeNewswire
    News headline image
    Research Update
    From Scancell Holdings Plc
    Via GlobeNewswire
    News headline image
    Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Caledonia Mining Corporation Plc Appointment of July Ndlovu as Independent Non-Executive Director
    From Caledonia Mining Corporation Plc
    Via GlobeNewswire
    News headline image
    HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®
    From HUTCHMED (China) Limited
    Via GlobeNewswire

    Frequently Asked Questions

    Is Leishen Energy Holding Co., Ltd. - Ordinary Shares publicly traded?
    Yes, Leishen Energy Holding Co., Ltd. - Ordinary Shares is publicly traded.
    What exchange does Leishen Energy Holding Co., Ltd. - Ordinary Shares trade on?
    Leishen Energy Holding Co., Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Leishen Energy Holding Co., Ltd. - Ordinary Shares?
    The ticker symbol for Leishen Energy Holding Co., Ltd. - Ordinary Shares is LSE on the Nasdaq Stock Market
    What is the current price of Leishen Energy Holding Co., Ltd. - Ordinary Shares?
    The current price of Leishen Energy Holding Co., Ltd. - Ordinary Shares is 4.570
    When was Leishen Energy Holding Co., Ltd. - Ordinary Shares last traded?
    The last trade of Leishen Energy Holding Co., Ltd. - Ordinary Shares was at 01/08/26 01:19 PM ET
    What is the market capitalization of Leishen Energy Holding Co., Ltd. - Ordinary Shares?
    The market capitalization of Leishen Energy Holding Co., Ltd. - Ordinary Shares is 70.83M
    How many shares of Leishen Energy Holding Co., Ltd. - Ordinary Shares are outstanding?
    Leishen Energy Holding Co., Ltd. - Ordinary Shares has 71M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.